1.370EUR-7.93%Mkt Cap: 130.41M EURP/E: —Last update: 2026-06-01
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap130.41M EUR
Enterprise Value93.24M EUR
Revenue (TTM)852.60M EUR
Gross Profit144.80M EUR
Net Income (TTM)-211.20M EUR
Revenue/Share9.003 EUR
Last Price1.370 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees3.0K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINFR0014008VX5
Valuation
P/E (Trailing)—
P/E (Forward)-7.97
PEG—
EV/EBITDA0.72
EV/Revenue0.11
P/S0.17
P/B0.24
EPS (TTM)-2.23
EPS (Forward)-0.19
52W Range
1.2206% of range3.572
52W High3.572 EUR
52W Low1.220 EUR
Profitability
Gross Margin16.98%
Oper. Margin-2.24%
EBITDA Margin15.21%
Profit Margin-24.77%
ROE-26.80%
ROA-16.19%
Growth
Revenue Growth-6.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF128.50M EUR
CapEx (TTM)78.50M EUR
FCF Margin18.47%
FCF Yield120.75%
Net Debt-48.40M EUR
Net Debt/EBITDA-0.37
Balance Sheet
Debt/Equity0.08
Current Ratio2.60
Quick Ratio0.90
Book Value/Sh6.177 EUR
Cash/Share1.196 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.760 EUR
Target Range1.000 EUR – 2.900 EUR
# Analysts5
Ownership
Shares Out.95.19M
Float50.46M
Insiders34.99%
Institutions36.33%
Technical
SMA 501.356 (+1.0%)
SMA 2002.323 (-41.0%)
Beta0.96
S&P 52W Chg27.94%
Avg Vol (30d)177.59K
Avg Vol (10d)144.02K
Technical Indicators
RSI (14)57.7
MACD0.0189
MACD Signal0.0206
MACD Hist.-0.0017
BB Upper1.522 EUR
BB Middle1.467 EUR
BB Lower1.412 EUR
BB Width7.47%
ATR (14)0.0525 EUR
Vol Ratio (20d)0.90x